There is an extraordinary contradiction in the global defense industry. The United States and its allies are struggling to replenish depleted ammunition inventories, missile interceptors are being consumed faster than manufacturers can replace them, and military planners are discovering that modern warfare requires far greater industrial capacity than they had anticipated. Yet shares of major American defense contractors have been falling, sometimes sharply. Lockheed Martin, Northrop Grumman, General Dynamics and other established defense manufacturers are operating in what should be one of the most favorable demand environments in decades. Instead, Wall Street is treating them with growing caution. The explanation is that military demand and shareholder returns are two different things, and the gap between them has become increasingly important.
The decline is substantial. By early October 2026, the iShares U.S. Aerospace & Defense ETF had fallen as much as 18% from its August peak, while several leading defense contractors suffered even steeper losses. Lockheed Martin shares were nearly 28% below their March high in early October. These declines are particularly striking against the background of continuing military operations, expanding procurement requirements and widespread concerns about the ability of Western countries to sustain prolonged conflicts. Investors are not questioning whether governments need more weapons. They are questioning how much money defense manufacturers will actually make from producing them.
The ammunition shortage is real, and in some categories it has become a strategic problem. The war in Ukraine, military operations involving Iran and the continuing demand for air defense systems have exposed serious weaknesses in Western military inventories. American production of 155-millimeter artillery ammunition reached approximately 36,000 rounds per month in March 2026, far below the previously established target of 100,000. Similar constraints affect missile production, particularly solid rocket motors, specialized electronics and complex interceptors. The difficulty is not insufficient demand but the inability of manufacturing facilities, suppliers and production processes to deliver the required quantities. An empty ammunition depot represents an urgent military requirement, but it does not automatically translate into immediate revenue or higher profits for a defense contractor.
This distinction is fundamental. Governments may urgently need hundreds of thousands of artillery shells or thousands of missile interceptors, but manufacturers cannot simply double production overnight. New facilities require substantial capital investment, specialized equipment, qualified personnel, reliable subcontractors and lengthy certification procedures. Even when the Pentagon announces a multibillion-dollar procurement program, actual production and payments may be spread over many years. Investors must therefore evaluate not only the headline contract value but also the timing of deliveries, the required investment and the margins ultimately earned. A company can accumulate an impressive order backlog while simultaneously experiencing pressure on its free cash flow.
Recent procurement agreements illustrate the paradox. Raytheon, part of RTX, secured a multiyear agreement worth up to $6.3 billion for Standard Missile-3 Block IB interceptors, alongside a much larger agreement for Standard Missile-6 production. Lockheed Martin obtained a Patriot missile contract with a potential value of up to $58.6 billion. These figures confirm the enormous strategic importance of rebuilding American missile inventories, but they do not mean that the entire contract value will immediately become revenue. Maximum contract ceilings are not guaranteed orders, and expanding manufacturing capacity requires spending long before additional weapons are delivered. Wall Street understands this distinction, even when the headline numbers appear spectacular.
There is another uncomfortable reality for defense shareholders. The industry’s largest customer is also its most powerful regulator. Unlike commercial technology companies, defense contractors cannot freely raise prices simply because demand exceeds supply. Military procurement is governed by negotiated contracts, competitive bidding, cost controls, congressional appropriations and political oversight. A shortage of missile interceptors does not necessarily translate into higher profit margins. It may instead produce demands for faster delivery, additional capital expenditure and tighter supervision of contractor performance. The Trump administration’s efforts to restrict dividends and share repurchases by companies that fail to accelerate production have introduced an additional source of uncertainty for investors accustomed to steady shareholder distributions.
The financial consequences of expanding production are considerable. Building ammunition plants and missile assembly lines consumes cash long before the additional capacity generates revenue. Manufacturers must purchase equipment, expand facilities, recruit workers and secure supplies of explosives, propellants, electronics and precision components. If these investments are financed through borrowing, interest expenses increase. If they are financed internally, less cash remains available for dividends, share repurchases and other corporate purposes. Investors can therefore view the same ammunition shortage that creates extraordinary long-term demand as a source of near-term financial strain. A factory expansion that makes perfect strategic sense for the Pentagon may not produce attractive returns for shareholders for several years.
Valuation is another important factor. Defense shares benefited from escalating geopolitical tensions and expectations of sustained military spending. Much of the favorable outlook was incorporated into stock prices before the latest production contracts were announced. When investors have already paid a premium for years of expected growth, even a positive development may fail to lift the share price if it does not exceed expectations. A growing order book is not necessarily a new reason to buy when the market has already anticipated it. The recent decline partly reflects the reassessment of those expectations, compounded by broader concerns about interest rates, federal deficits and the future direction of defense appropriations.
Political uncertainty adds another layer. American military spending depends on annual budget decisions, congressional negotiations and changes in procurement priorities. Even when there is broad agreement that ammunition inventories must be rebuilt, there can be considerable disagreement over how much money should be allocated, which weapons should receive priority and how contractors should be compensated. The administration’s efforts to reform defense acquisition introduce the possibility of changes in contract structures and competitive relationships. For investors, a large military requirement is not the same thing as an approved, funded and profitable production program.
The industry’s traditional business model is also facing a competitive challenge. New defense technology companies are increasingly promoting cheaper autonomous systems, drones, software-defined weapons and manufacturing methods designed for rapid scaling. Recent conflicts have demonstrated that sophisticated weapons remain indispensable, but they cannot be the only answer to large-scale attrition. An interceptor costing millions of dollars may be effective against an incoming missile, yet using such systems against much cheaper threats creates an unfavorable economic equation. This does not eliminate demand for advanced missile defense, but it raises questions about how future procurement budgets will be distributed between established contractors and emerging suppliers.
The ammunition shortage consequently creates different opportunities across the defense industry. Manufacturers of artillery shells, explosives, propellants, solid rocket motors and missile components may benefit directly from replenishment programs, although their ability to increase output remains constrained by production capacity. Large defense conglomerates, meanwhile, have extensive exposure to aircraft, naval systems, space programs, electronics and other businesses whose performance does not necessarily track ammunition demand. Buying shares in a major defense contractor is not the same as investing exclusively in ammunition production. Investors expecting a straightforward relationship between depleted arsenals and rising defense share prices may be overlooking the complexity of these businesses.
There is also a difference between a temporary wartime surge and a sustainable industrial expansion. Governments are demanding greater production capacity, but manufacturers must decide whether those requirements will remain in place long enough to justify permanent investment. Building a new production line is relatively straightforward compared with maintaining it profitably over a decade or more. Defense companies remember periods when military spending expanded rapidly during conflicts and contracted afterward. Without credible multiyear purchasing commitments, they face the risk of investing heavily in facilities that may eventually operate below capacity. Governments want industrial readiness, while shareholders want capital discipline. Reconciling these objectives is not always easy.
It would nevertheless be a mistake to interpret falling defense stocks as evidence that military demand is weakening. Lockheed Martin and RTX have raised their 2026 forecasts as replenishment requirements strengthened. Lockheed Martin has also outlined plans to expand annual PAC-3 interceptor production capacity from roughly 600 units to 2,000. These developments suggest that the underlying industrial opportunity remains substantial. The question is how quickly increased demand can be converted into production, revenue, earnings and ultimately cash returned to shareholders.
The coming quarters will test whether defense manufacturers can turn their enormous backlogs into stronger financial performance. Investors will be watching production rates, operating margins, free cash flow, capital expenditure, congressional funding and the conversion of framework agreements into funded orders. Evidence of accelerating deliveries without a corresponding deterioration in profitability would strengthen the investment case. Continued production delays, rising costs or restrictions on shareholder distributions could have the opposite effect, even while military demand remains exceptionally strong.
The deeper problem is that the Western defense industry is being asked to prepare for an era of sustained, high-intensity warfare after decades of operating with comparatively limited surge capacity. Rebuilding that industrial base is strategically necessary, but it is expensive, slow and commercially complicated. The shortage of ammunition demonstrates the need for more manufacturing capacity; it does not establish how much profit existing shareholders will earn from building it.
There is a certain irony in the situation. For years, investors worried that the end of major military operations would reduce defense spending and weaken the industry’s growth prospects. Today, the concern is almost the opposite. Demand is so intense that manufacturers are being pushed to expand capacity faster than their traditional business models comfortably allow, while their government customers are demanding greater output, tighter accountability and potentially lower costs.
That is why defense stocks can fall while ammunition depots are running empty. The military needs weapons immediately, governments need manufacturers to expand, and investors need evidence that the expansion will generate attractive financial returns. All three objectives are connected, but they are not identical. Until production capacity, procurement funding and profitability begin moving together, the defense sector may continue to present one of the market’s more unusual contradictions: exceptionally strong demand accompanied by disappointing share-price performance.
The world may be running short of ammunition, but Wall Street is not running short of reasons to sell defense stocks.